Geen internetverbinding — de opgeslagen versie van de pagina wordt getoond.

Quest Diagnostics…

USUSD
← Naar de screener

Quest Diagnostics Incorporated (LSE:0KSX) — Medical Specialities. Aantal beurzen waarop de aandelen van het bedrijf worden verhandeld: 2. Op deze pagina — koers en grafiek, dividenden, grootste aandeelhouders en historiek van het aantal aandelen.

Over het bedrijf

Website
questdiagnostics.com
Beleggersrelaties
ir.questdiagnostics.com/overview/default.aspx
Sector
Health Care · Medical Specialities
Hoofdkantoor
Madison, United States
CEO
Steve Rusckowski
Werknemers
46 000
Opgericht
1967
Beursgenoteerd sinds
29.01.2018 (LSE:0KSX)
Uitstaande aandelen
110.37 mln. per 2026-07-15
Free float
109.81 mln.
Marktkapitalisatie
25.21 mld. USD
Insiders
0.43%
Institutionele beleggers
98.9%
Branche (SIC)
Services-Medical Laboratories
LEI
8MCWUBXQ0WE04KMXBX50
Uitkeringsratio
34.2%
FCF
1.35 mld. USD
27%
Schuld
5.64 mld. USD
3.7 jr FCF
Dividendreeks
22 jr
Winst, FCF en uitbetaalde dividenden — voor de 12 maanden tot 30.06.2026 (het laatste rapport van het bedrijf).
Beschrijving

Quest Diagnostics Incorporated provides diagnostic testing and services in the United States. The company develops and delivers diagnostic information services, such as routine, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services. It also provides services under the Quest Diagnostics brand, as well as under the AmeriPath, Dermpath Diagnostics, ExamOne, and Quanum brands to physicians, hospitals, patients and consumers, health plans, government agencies, employers, retailers, pharmaceutical companies and insurers commercial clinical laboratories, and accountable care organizations through a network of laboratories, patient service centers, phlebotomists in physician offices, call centers and mobile phlebotomists, nurses, and other health and wellness professionals. In addition, the company offers risk assessment services for the life insurance industry; healthcare IT healthcare providers and payers; testing and medical director services at hospital laboratories; test offerings in cardiometabolic and endocrine; cancer; clinical drug monitoring and toxicology; infectious disease, including autoimmune; neurology diagnostics, including Alzheimer's disease; and women's health, such as prenatal genetic; workplace drug testing, testing urine, hair, and oral fluid specimens services; and employer population health services, including biometric screenings, flu shots, and related preventative services. Further, it provides population health solutions; extended care services; develops in vitro diagnostic tests; laboratory diagnostic information and digital health connectivity systems; underwriting support services, including data gathering, paramedical examinations, and clinical laboratory testing and analytics; and national specimen collection and health data solutions. Quest Diagnostics Incorporated was founded in 1967 and is headquartered in Secaucus, New Jersey.

Beurzen en tickers

BeursTickerValutaPrijsType
US USA StocksDGX primairUSD230.81 +1.65%gewone aandelen
LSE London Stock Exchange0KSX IOBUSD231.43 +0.00%gewone aandelen

Koers over 3 maanden

stijgingsdag dalingsdag ex-dividenddatum betaaldatumBeweeg over / tik op een dag — openings-, slot-, hoogste en laagste koers

Dividenden

Afgelopen 12 maanden, US:DGX: 3.38 USD (4 uitk.)

Quest Diagnostics Incorporated (DGX) betaalt elk kwartaal dividend uit. In de afgelopen 12 maanden werd 3.38 USD per aandeel betaald (betalingen: 4). Dat is ongeveer 1.46% van de huidige aandelenkoers. Op basis van de betalingsgeschiedenis wordt de volgende ex-dividenddatum verwacht rond 05.01.2027. Ononderbroken dividendgeschiedenis: 22 jaar.

Ex-datumUitbetalingBedrag%TypeTicker
2026-10-062026-10-210.8600 USD0.4/1.5 %per kwartaalUS:DGX
2026-07-082026-07-220.8600 USD0.4/1.4 %per kwartaalUS:DGX
2026-04-062026-04-200.8600 USD0.4/1.4 %per kwartaalUS:DGX
2026-01-132026-01-280.8000 USD0.3/1.4 %per kwartaalUS:DGX
2025-10-032025-10-200.8000 USD0.3/≈1.4 %per kwartaalUS:DGX
2025-07-072025-07-210.8000 USD0.3/≈1.4 %per kwartaalUS:DGX
2025-04-072025-04-210.8000 USD0.3/≈1.4 %per kwartaalUS:DGX

Nieuws deze week

Nog geen nieuws van de website van het bedrijf.

advertentie

Grootste aandeelhouders

HouderBelangAandelenRapportdatum
Blackrock Inc.8.4%9.28 mln.2026-06-30
Vanguard Capital Managem…6.55%7.23 mln.2026-06-30
Vanguard Portfolio Manag…5.55%6.13 mln.2026-06-30
State Street Corporation5%5.52 mln.2026-06-30
Price (T.Rowe) Associate…4.93%5.44 mln.2026-06-30
Boston Partners4.3%4.74 mln.2026-06-30
JPMORGAN CHASE & CO3.19%3.52 mln.2026-06-30
VANGUARD INDEX FUNDS-Van…3.18%3.51 mln.2026-06-30
Geode Capital Management…2.84%3.14 mln.2026-06-30
VANGUARD INDEX FUNDS-Van…2.6%2.87 mln.2026-06-30
Morgan Stanley2.23%2.46 mln.2026-06-30
VANGUARD INDEX FUNDS-Van…2.17%2.4 mln.2026-06-30
Edgepoint Investment Gro…2.04%2.25 mln.2026-06-30
iShares Trust-iShares Co…1.33%1.47 mln.2026-08-31
Fidelity Concord Street…1.3%1.43 mln.2026-07-31
SPDR S&P 500 ETF TRUST-S…1.23%1.36 mln.2026-08-31
John Hancock Funds III-D…1.09%1.2 mln.2026-07-31
JPMorgan Trust II-JPMorg…1.04%1.15 mln.2026-06-30
T. Rowe Price Dividend G…1%1.11 mln.2026-06-30
John Hancock Funds III-D…0.96%1.06 mln.2026-07-31
DAVIS J E CAUSEY (Chief…≈0.13%142 4232026-03-04
DAVIS JAMES E (Chief Exe…≈0.11%122 4232026-09-01
DOHERTY CATHERINE T (Off…≈0.06%71 6242026-03-05
PREVOZNIK MICHAEL E (Gen…≈0.04%42 3372026-08-28
DEPPE MICHAEL J (Officer…≈0.03%35 1962026-03-04
SAMAD SAMER ABDUL (Chief…≈0.03%33 4782026-07-22
RING TIMOTHY M (Director…≈0.03%31 1402026-05-20
PFEIFFER GARY M (Directo…≈0.03%31 0052026-05-20
MAIN TIMOTHY L (Director…≈0.02%27 4602026-07-22
GREGG VICKY B (Director)≈0.02%18 3862026-07-22